Cargando…
Case report: Significant relief of linezolid-induced peripheral neuropathy in a pre-XDR-TB case after acupuncture treatment
The revised WHO guidelines on multidrug- or rifampicin-resistant tuberculosis (MDR/RR-TB) include linezolid in the core drug group. Common adverse events of prolonged linezolid use are bone marrow suppression and peripheral neuropathy (PN). Available measures against linezolid-induced PN (LIPN) ofte...
Autores principales: | Mo, Yuping, Zhu, Zhu, Tan, Jie, Liang, Zhilin, Wu, Jiahui, Chen, Xingcheng, Hu, Ming, Zhang, Peize, Deng, Guofang, Fu, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493459/ https://www.ncbi.nlm.nih.gov/pubmed/36158953 http://dx.doi.org/10.3389/fneur.2022.985499 |
Ejemplares similares
-
Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China
por: Zhang, Peize, et al.
Publicado: (2022) -
A Case Report and Literature Review of the Outcome of Linezolid-Induced Optic and Peripheral Neuropathy in Patients With Multidrug-Resistant Pulmonary TB
por: Bano, Safia, et al.
Publicado: (2022) -
Mutation detection and minimum inhibitory concentration determination against linezolid and clofazimine in confirmed XDR-TB clinical isolates
por: Singh, Kamal, et al.
Publicado: (2022) -
Acupuncture for painful diabetic peripheral neuropathy: a systematic review and meta-analysis
por: Zhou, Luolin, et al.
Publicado: (2023) -
XDR-TB in South Africa: Back to TB Sanatoria Perhaps?
por: Sakoane, Ramalitse
Publicado: (2007)